Your browser doesn't support javascript.
loading
Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey.
Shi, Ju-Fang; Wang, Le; Ran, Jian-Chao; Wang, Hong; Liu, Cheng-Cheng; Zhang, Hai-Zeng; Yang, Lin; Shi, Su-Sheng; Jiang, Li-Ming; Fan, Jin-Hu; Zhang, Yue-Ming; Wang, Wei-Hu; Ren, Jian-Song; Zhu, Lin; Zheng, Zhao-Xu; Sun, Yong-Kun; Zou, Shuang-Mei; Jiang, Jun; Chen, Bo; Chen, Hong-Da; Liu, Guo-Xiang; Yang, Li; Huang, Yun-Chao; Guo, Lan-Wei; Wang, De-Bin; Zhang, Yong-Zhen; Mao, A-Yan; Wang, Jia-Lin; Gong, Ji-Yong; Wei, Dong-Hua; Qiu, Wu-Qi; Song, Bing-Bing; Zhang, Kai; Li, Ni; Feletto, Eleonora; Lew, Jie-Bin; Qiao, You-Lin; Chen, Wan-Qing; Dai, Min; He, Jie.
Affiliation
  • Shi JF; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Wang L; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Ran JC; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Wang H; School of Public Health, Affiliated Cancer Hospital, Xinjiang Medical University, Xinjiang, China.
  • Liu CC; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Zhang HZ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Yang L; Department of Colorectal Surgery, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Shi SS; Department of Medical Oncology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Jiang LM; Department of Pathology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Fan JH; Department of Imaging Diagnosis, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Zhang YM; Department of Cancer Epidemiology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Wang WH; Department of Endoscopy, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Ren JS; Department of Radiation Oncology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Zhu L; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Zheng ZX; School of Public Health, Affiliated Cancer Hospital, Xinjiang Medical University, Xinjiang, China.
  • Sun YK; Department of Colorectal Surgery, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Zou SM; Department of Medical Oncology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Jiang J; Department of Pathology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Chen B; Department of Imaging Diagnosis, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Chen HD; Department of Radiation Oncology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Liu GX; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Yang L; School of Health Management, Harbin Medical University, Harbin, China.
  • Huang YC; School of Public Health, Guangxi Medical University, Nanning, China.
  • Guo LW; Department of Thoracic Surgery, Yunnan Cancer Hospital, Kunming, China.
  • Wang DB; Affiliated Cancer Hospital, Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Zhang YZ; School of Health Management, Anhui Medical University, Hefei, China.
  • Mao AY; Department of Epidemiology, Shanxi Provincial Cancer Hospital, Taiyuan, China.
  • Wang JL; Division for Strategic Information Research in Public Health, Institute of Medical Information, CAMS & PUMC, Beijing, China.
  • Gong JY; Shandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University, Jinan, China.
  • Wei DH; Shandong Academy of Medical Sciences, Shandong Provincial Cancer Hospital Affiliated to Shandong University, Jinan, China.
  • Qiu WQ; Department of Cancer Prevention, Anhui Cancer Hospital, Hefei, China.
  • Song BB; Division for Strategic Information Research in Public Health, Institute of Medical Information, CAMS & PUMC, Beijing, China.
  • Zhang K; Heilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University, Harbin, China.
  • Li N; Department of Physical Examination on Cancer, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Feletto E; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • Lew JB; Cancer Research Division, Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia.
  • Qiao YL; Cancer Research Division, Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia.
  • Chen WQ; Department of Cancer Epidemiology, NCC/NCRCC/Cancer Hospital, CAMS & PUMC, Beijing, China.
  • Dai M; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
  • He J; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital (NCC/NCRCC/Cancer Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China.
Cancer ; 127(11): 1880-1893, 2021 06 01.
Article in En | MEDLINE | ID: mdl-33784413
ABSTRACT

BACKGROUND:

Colorectal cancer (CRC) is the third most common cancer in China, however, publicly available, descriptive information on the clinical epidemiology of CRC is limited.

METHODS:

Patients diagnosed with primary CRC during 2005 through 2014 were sampled from 13 tertiary hospitals in 9 provinces across China. Data related to sociodemographic characteristics, the use of diagnostic technology, treatment adoption, and expenditure were extracted from individual medical records.

RESULTS:

In the full cohort of 8465 patients, the mean ± SD age at diagnosis was 59.3 ± 12.8 years, 57.2% were men, and 58.7% had rectal cancer. On average, 14.4% of patients were diagnosed with stage IV disease, and this proportion increased from 13.5% in 2005 to 20.5% in 2014 (P value for trend < .05). For diagnostic techniques, along with less use of x-rays (average, 81.6%; decreased from 90.0% to 65.7%), there were increases in the use of computed tomography (average, 70.4%; increased from 4.5% to 90.5%) and magnetic resonance imaging (average, 8.8%; increased from 0.1% to 20.4%) over the study period from 2005 to 2014. With regard to treatment, surgery alone was the most common (average, 50.1%), but its use decreased from 51.3% to 39.8% during 2005 through 2014; and the use of other treatments increased simultaneously, such as chemotherapy alone (average, 4.1%; increased from 4.1% to 11.9%). The average medical expenditure per patient was 66,291 Chinese Yuan (2014 value) and increased from 47,259 to 86,709 Chinese Yuan.

CONCLUSIONS:

The increasing proportion of late-stage diagnoses presents a challenge for CRC control in China. Changes in diagnostic and treatment options and increased expenditures are clearly illustrated in this study. Coupled with the recent introduction of screening initiatives, these data provide an understanding of changes over time and may form a benchmark for future related evaluations of CRC interventions in China.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Health Expenditures / Facilities and Services Utilization Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Year: 2021 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Health Expenditures / Facilities and Services Utilization Type of study: Health_economic_evaluation / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Cancer Year: 2021 Type: Article Affiliation country: China